http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102441113-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_952d1add5a71cdedcc32f4776056049e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abdc10b72307d7576f354a2b1c79d00d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
filingDate 2011-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2323b460695bc6c5dbba3cde9b49b964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cfd188903fefe934f2a26e6d3dfefd9
publicationDate 2013-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102441113-B
titleOfInvention Bergenia scopulosa traditional Chinese medicinal composition and preparation method thereof
abstract The invention relates to a bergenia scopulosa traditional Chinese medicinal composition and a preparation method thereof. The traditional Chinese medicinal composition is prepared from 29 traditional Chinese medicines, namely bergenia scopulosa, caryophyllaceae, cortex acanthopanacis, encommiae ulmoide, angelica, panax pseudo-ginseng, iris tectorum, aconite-leaved ampelopsis root bark, largeleaf gentian root, elecampane, cirald daphne bark, Chinese starjasmine stem, common monkshood mother root, cantonese disporum root, aconitum pendulum busch, kusnezoff monkshood root, hovenia acerba lindl, polygonum suffultum, safflower, myrrh, disporopsis fuscopicta, valerian, lycopodium clavatum, achyranthes bidentata, red-rooted salvia root, aconitum cannabifolium, Bowley Sage Root, Sambucus chinensis, polyphylla and frankincense. The bergenia scopulosa traditional Chinese medicinal composition has the effects of activating blood circulation to dissipate blood stasis, dispelling wind-evil and wetness-evil, and relieving swelling and pain, and is mainly used for treating rheumarthritis, lumbar muscle strain, fracture and soft tissue injury. The clinical pharmacodynamics test effect of the composition is obviously improved; the bioavailability is high; and the composition does not have any toxic and side effects.
priorityDate 2011-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 24.